Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2011

01-08-2011 | Image of the Month

123I-Metaiodobenzylguanidine ‘superscan’ in an adult patient with neuroblastoma

Authors: Víctor Andrés Marín Oyaga, Juan Ignacio Cuenca Cuenca, Juan Luis Tirado Hospital, Rosa Fernández López, Isabel Borrego Dorado, Ricardo Vázquez Albertino

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2011

Login to get access

Excerpt

Neuroblastoma is extremely rare in patients over 10 years old [1]. 123I-MIBG has a high sensitivity for the diagnosis of primary and metastatic neuroblastoma [2]. …
Literature
1.
Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and Other Neuroendocrine Tumors. Semin Nucl Med. 2007;37:286–302.PubMedCrossRef
2.
Díez Jimenez L, Mitjavila Casanovas M. Gammagrafía con MIBG en el neuroblastoma: algo más que una imagen. Rev Esp Med Nucl. 2006;25:118–43.PubMedCrossRef
3.
Ravizzini G, Pryma DA, Meirelles GS, Divgi CR. I-123 MIBG scan of metastatic neuroblastoma mimicking a bone scan. Clin Nucl Med. 2006;31(9):558–60.PubMedCrossRef
Metadata
Title
123I-Metaiodobenzylguanidine ‘superscan’ in an adult patient with neuroblastoma
Authors
Víctor Andrés Marín Oyaga
Juan Ignacio Cuenca Cuenca
Juan Luis Tirado Hospital
Rosa Fernández López
Isabel Borrego Dorado
Ricardo Vázquez Albertino
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1791-3

Other articles of this Issue 8/2011

European Journal of Nuclear Medicine and Molecular Imaging 8/2011 Go to the issue

Original Article

Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607

Original Article

Washout of 82Rb as a marker of impaired tissue integrity, obtained by list-mode cardiac PET/CT: relationship with perfusion/metabolism patterns of myocardial viability

Society Communications

Becquerel Medal presented to Professor Helmut Maecke

Original Article

What is the relationship between 18F-FDG aortic aneurysm uptake on PET/CT and future growth rate?

Review Article

What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis

Letter to the Editor

Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status